PURPOSE: To describe comorbidities in breast cancer patients at diagnosis and examine factors associated with self-reported comorbidities 30 months post-diagnosis. METHODS: Nine hundred forty one of 1,171 women had a medical record abstract and a follow-up survey in the Health, Eating, Activity and Lifestyle Study. RESULTS: We compared our breast cancer cohort to a contemporaneous nationally-representative sample of age, race/ethnicity and education matched women without cancer (n = 865). Breast cancer patients did not have substantially more comorbidities than women without breast cancer. Women with a hospital record of congestive heart failure significantly less often received chemotherapy or radiation following breast conserving surgery. In multivariate analysis, women who received chemotherapy alone (OR = 3.2; 95% CI: 1.5-6.8), chemotherapy plus radiation (OR = 1.9; 95% CI: 1.02-3.7) or radiation plus tamoxifen (OR = 1.9; 95% CI: 1.1-3.2) were significantly more likely to report at least one new comorbid condition following breast cancer diagnosis than women who received no chemotherapy, tamoxifen or radiation. Overall, women who received adjuvant therapy were more likely to have new comorbidities. CONCLUSIONS: Comorbidities were not substantially different in breast cancer patients than the non-cancer matched controls. Future research should focus on efforts to minimize comorbidities related to chemotherapy and other combination therapy.
PURPOSE: To describe comorbidities in breast cancerpatients at diagnosis and examine factors associated with self-reported comorbidities 30 months post-diagnosis. METHODS: Nine hundred forty one of 1,171 women had a medical record abstract and a follow-up survey in the Health, Eating, Activity and Lifestyle Study. RESULTS: We compared our breast cancer cohort to a contemporaneous nationally-representative sample of age, race/ethnicity and education matched women without cancer (n = 865). Breast cancerpatients did not have substantially more comorbidities than women without breast cancer. Women with a hospital record of congestive heart failure significantly less often received chemotherapy or radiation following breast conserving surgery. In multivariate analysis, women who received chemotherapy alone (OR = 3.2; 95% CI: 1.5-6.8), chemotherapy plus radiation (OR = 1.9; 95% CI: 1.02-3.7) or radiation plus tamoxifen (OR = 1.9; 95% CI: 1.1-3.2) were significantly more likely to report at least one new comorbid condition following breast cancer diagnosis than women who received no chemotherapy, tamoxifen or radiation. Overall, women who received adjuvant therapy were more likely to have new comorbidities. CONCLUSIONS: Comorbidities were not substantially different in breast cancerpatients than the non-cancer matched controls. Future research should focus on efforts to minimize comorbidities related to chemotherapy and other combination therapy.
Authors: Karin B Michels; Caren G Solomon; Frank B Hu; Bernard A Rosner; Susan E Hankinson; Graham A Colditz; JoAnn E Manson Journal: Diabetes Care Date: 2003-06 Impact factor: 19.112
Authors: Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake Journal: J Natl Cancer Inst Date: 2013-08-29 Impact factor: 13.506
Authors: Corinne R Leach; Kathryn E Weaver; Noreen M Aziz; Catherine M Alfano; Keith M Bellizzi; Erin E Kent; Laura P Forsythe; Julia H Rowland Journal: J Cancer Surviv Date: 2014-10-16 Impact factor: 4.442
Authors: Krista Beth Highland; Alejandra Hurtado-de-Mendoza; Cassandra A Stanton; Chiranjeev Dash; Vanessa B Sheppard Journal: Support Care Cancer Date: 2014-09-21 Impact factor: 3.603
Authors: Marian L Neuhouser; Ashley Wilder Smith; Stephanie M George; James T Gibson; Kathy B Baumgartner; Richard Baumgartner; Catherine Duggan; Leslie Bernstein; Anne McTiernan; Rachel Ballard Journal: Breast Cancer Res Treat Date: 2016-10-21 Impact factor: 4.872
Authors: Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger Journal: Breast Cancer Res Treat Date: 2014-06-18 Impact factor: 4.872
Authors: Sarah Nechuta; Wei Lu; Ying Zheng; Hui Cai; Ping-Ping Bao; Kai Gu; Wei Zheng; Xiao Ou Shu Journal: Breast Cancer Res Treat Date: 2013-04-19 Impact factor: 4.872
Authors: Stephanie M George; Catherine M Alfano; Marian L Neuhouser; Ashley W Smith; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash Journal: J Cancer Surviv Date: 2014-07-08 Impact factor: 4.442